Lexaria Bioscience Corp(LEXX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LEXX Lexaria Bioscience Corp

交易中 10-01 11:12:36 EDT

3.15

+0.00

0.00%

最高3.15	最低2.95	成交量1.37万
今开3.15	昨收3.15	日振幅6.35%
总市值520.54万	流通市值508.55万	总股本165.25万
成交额4.17万	换手率0.85%	流通股本161.44万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LEXX","market":"US","secType":"STK","nameCN":"Lexaria Bioscience Corp","latestPrice":3.15,"timestamp":1790867537999,"preClose":3.15,"halted":0,"volume":13696,"delay":0,"changeRate":0,"floatShares":1614429,"shares":1652500,"eps":-5.142899,"marketStatus":"交易中","change":0,"latestTime":"10-01 11:12:36 EDT","open":3.15,"high":3.15,"low":2.95,"amount":41749.229183999996,"amplitude":0.063492,"askPrice":3.29,"askSize":100,"bidPrice":3.07,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-5.142899,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.15,"preHourTrading":{"tag":"盘前","latestPrice":3.2096,"preClose":3.15,"latestTime":"07:32 EDT","volume":27,"amount":86.456997,"timestamp":1790854333816,"change":0.0596,"changeRate":0.018921,"amplitude":0.020444},"postHourTrading":{"tag":"盘后","latestPrice":3.15,"preClose":3.15,"latestTime":"16:10 EDT","volume":3,"amount":9.225,"timestamp":1790799005646,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.128593},"requestUrl":"/m/hq/s/LEXX","defaultTab":"news","newsList":[{"id":"1180692519","title":"Lexaria Bioscience 携手 MTA 探索其自主研发的 PEGbio 分子与 DehydraTECH 技术在 GLP-1 领域的应用潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1180692519","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180692519?lang=zh_cn&edition=full","pubTime":"2026-08-13 21:13","pubTimestamp":1786626826,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience 正与 MTA 展开合作，旨在深入探究其自主研发的 PEGbio 分子与 DehydraTECH 技术相结合，在 GLP-1 药物研发领域的应用前景。此次合作中，MTA 将对这项整合了专有 PEGbio 分子的 DehydraTECH 技术进行系统性评估，以验证其在该行业中的潜在价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512859814","title":"Lexaria Bioscience Corp.盘中异动 快速拉升5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512859814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512859814?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:52","pubTimestamp":1739976766,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时52分，Lexaria Bioscience Corp.股票出现波动，股价急速上涨5.29%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为333.70%、220.56%、71.44%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Allogene Therapeutics, Inc.，振幅分别为207.68%、98.28%、36.97%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192252479628d165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192252479628d165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512199586","title":"Lexaria Bioscience Corp.盘中异动 快速下挫5.00%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512199586?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:28","pubTimestamp":1739906905,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时28分，Lexaria Bioscience Corp.股票出现异动，股价快速下挫5.00%。截至发稿，该股报1.52美元/股，成交量4.5936万股，换手率0.26%，振幅8.12%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为1.03%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190328269627c705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190328269627c705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXXW","LEXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511694261","title":"Lexaria Bioscience Corp.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511694261?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:23","pubTimestamp":1739546590,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时23分，Lexaria Bioscience Corp.股票出现波动，股价大幅拉升5.23%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2430.41%、627.61%、476.65%，振幅较大的相关个股有Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为66.93%、54.40%、43.67%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423231196232769&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423231196232769&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511257305","title":"Lexaria Bioscience Corp.盘中异动 早盘大幅拉升5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511257305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511257305?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457165,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Lexaria Bioscience Corp.股票出现异动，股价急速拉升5.26%。截至发稿，该股报1.60美元/股，成交量3809股，换手率0.02%，振幅0.00%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.17%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223245abcdb276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223245abcdb276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510135218","title":"Lexaria Bioscience Corp.盘中异动 股价大跌5.29%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510135218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510135218?lang=zh_cn&edition=full","pubTime":"2025-02-12 05:00","pubTimestamp":1739307603,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日05时00分，Lexaria Bioscience Corp.股票出现异动，股价大幅下跌5.29%。截至发稿，该股报1.61美元/股，成交量7.8471万股，换手率0.45%，振幅6.47%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为2.11%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120500039881fa6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120500039881fa6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510864524","title":"Lexaria Bioscience Corp.盘中异动 股价大跌5.56%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510864524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510864524?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:46","pubTimestamp":1739202394,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时46分，Lexaria Bioscience Corp.股票出现波动，股价大幅下跌5.56%。截至发稿，该股报1.68美元/股，成交量2.0399万股，换手率0.12%，振幅6.46%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.13%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234634abc9b58e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234634abc9b58e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509778124","title":"Lexaria Bioscience Corp.盘中异动 下午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509778124?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:22","pubTimestamp":1738956153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时22分，Lexaria Bioscience Corp.股票出现波动，股价快速跳水5.03%。截至发稿，该股报1.80美元/股，成交量5.5392万股，换手率0.32%，振幅5.34%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.72%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032233abc66659&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032233abc66659&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509230174","title":"Lexaria Bioscience Corp.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509230174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509230174?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:46","pubTimestamp":1738781201,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时46分，Lexaria Bioscience Corp.股票出现波动，股价急速拉升5.08%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为2.26%。其相关个股中，Transcode Therapeutics, Inc.、Invivyd, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4591.77%、2318.05%、1732.50%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、67.19%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206024641a23ab09d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206024641a23ab09d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","BK4007","LEXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507689096","title":"Lexaria Bioscience Corp.盘中异动 快速拉升5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507689096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507689096?lang=zh_cn&edition=full","pubTime":"2025-01-30 04:40","pubTimestamp":1738183213,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日04时40分，Lexaria Bioscience Corp.股票出现波动，股价大幅上涨5.85%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为1.41%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130044013a233a3f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130044013a233a3f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505443170","title":"Lexaria Bioscience Corp.盘中异动 股价大跌6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505443170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505443170?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:49","pubTimestamp":1737654559,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时49分，Lexaria Bioscience Corp.股票出现波动，股价大幅跳水6.54%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Nutriband Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为4676.99%、3737.83%、683.64%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为682.14%、105.88%、81.23%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240149199870df1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240149199870df1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXX","LEXXW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505077300","title":"Lexaria Bioscience Corp.盘中异动 大幅跳水6.19%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505077300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505077300?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:45","pubTimestamp":1737564345,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时45分，Lexaria Bioscience Corp.股票出现异动，股价急速下挫6.19%。截至发稿，该股报1.82美元/股，成交量7.009万股，换手率0.40%，振幅7.95%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.04%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123004545986f8df8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123004545986f8df8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","BK4007","LEXXW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504942636","title":"Lexaria Bioscience Corp.盘中异动 急速上涨5.26%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504942636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504942636?lang=zh_cn&edition=full","pubTime":"2025-01-17 03:53","pubTimestamp":1737057238,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日03时53分，Lexaria Bioscience Corp.股票出现波动，股价快速拉升5.26%。截至发稿，该股报2.00美元/股，成交量5.8467万股，换手率0.33%，振幅6.07%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.76%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117035359960647be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117035359960647be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LEXX","LEXXW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503509642","title":"Lexaria Bioscience Corp.盘中异动 早盘大幅上涨10.36%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503509642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503509642?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:30","pubTimestamp":1736951424,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时30分，Lexaria Bioscience Corp.股票出现异动，股价大幅上涨10.36%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Monte Rosa Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为181.16%、49.93%、45.93%，振幅较大的相关个股有Anixa Biosciences, Inc.、Biohaven Ltd.、Aptose Biosciences, Inc.，振幅分别为4.23%、4.22%、2.91%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223024ababf19a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223024ababf19a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503533179","title":"Lexaria Bioscience Corp.盘中异动 股价大跌6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503533179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503533179?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:52","pubTimestamp":1736787167,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时52分，Lexaria Bioscience Corp.股票出现异动，股价大幅下跌6.48%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为12176.86%、6816.54%、550.68%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、201.86%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400524796026ae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400524796026ae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","LEXX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502848590","title":"Lexaria Bioscience(LEXX.US)：2025年Q1财报实现营收18.392万美元，前值为15.128万美元，预期值为10万美元；每股收益为-0.16美元，前值为-0.13美元，预期值为-0.12美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502848590","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502848590?lang=zh_cn&edition=full","pubTime":"2025-01-11 05:41","pubTimestamp":1736545289,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience(LEXX.US)：2025年Q1财报实现营收18.392万美元，前值为15.128万美元，预期值为10万美元；每股收益为-0.16美元，前值为-0.13美元，预期值为-0.12美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/11054147365164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LEXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501207066","title":"Lexaria Bioscience Corp.盘中异动 早盘股价大涨9.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501207066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501207066?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:33","pubTimestamp":1736260418,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时33分，Lexaria Bioscience Corp.股票出现波动，股价快速上涨9.06%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Hoth Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Immuneering Corporation涨幅较大，Hoth Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃，换手率分别为784.59%、165.71%、98.55%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Immuneering Corporation，振幅分别为29.28%、21.99%、19.92%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223339a218e7af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223339a218e7af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","BK4007","LEXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501253503","title":"Lexaria Bioscience Corp.盘中异动 急速拉升5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501253503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501253503?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:55","pubTimestamp":1736175335,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时55分，Lexaria Bioscience Corp.股票出现波动，股价快速上涨5.32%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Cytomed Therapeutics Limited较为活跃，换手率分别为711.99%、261.85%、85.14%，振幅较大的相关个股有Scisparc Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为87.12%、46.90%、44.00%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622553595fa777b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622553595fa777b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500149763","title":"Lexaria Bioscience Corp.盘中异动 股价大跌5.22%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500149763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500149763?lang=zh_cn&edition=full","pubTime":"2025-01-04 00:53","pubTimestamp":1735923238,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日00时53分，Lexaria Bioscience Corp.股票出现波动，股价快速下挫5.22%。截至发稿，该股报2.18美元/股，成交量5.9416万股，换手率0.34%，振幅7.39%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.64%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104005358985a5451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104005358985a5451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXXW","BK4007","LEXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500973316","title":"Lexaria Bioscience Corp.盘中异动 早盘快速上涨6.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500973316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500973316?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:16","pubTimestamp":1735830990,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时16分，Lexaria Bioscience Corp.股票出现波动，股价大幅拉升6.19%。截至发稿，该股报2.23美元/股，成交量9713股，换手率0.06%，振幅3.81%。Lexaria Bioscience Corp.股票所在的生物技术行业中，整体涨幅为0.98%。Lexaria Bioscience Corp.公司简介：Lexaria Bioscience Corp的专利药物输送技术DehydraTECH，通过促进更有效的口服输送，改善了活性药物成分进入血液的方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231630ab9c01af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231630ab9c01af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEXX","LEXXW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexariabioscience.com","stockEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.7207},{"period":"3month","weight":-0.6251},{"period":"6month","weight":-0.7981},{"period":"1year","weight":-0.7796},{"period":"ytd","weight":-0.6596}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.024},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.1448},{"period":"ytd","weight":0.1184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lexaria Bioscience Corp.根据内华达州法律于2004年12月9日成立。该公司是一家生物技术公司，利用获得专利的DehydraTECHTM药物递送技术开发增强广泛的脂溶性活性分子和活性药物成分的生物利用度。DehydraTECH将亲脂性分子或原料药与特定的长链脂肪酸和载体化合物相结合，从而改善它们进入血液的方式，提高其有效性并允许较低的总体剂量，同时促进更健康的口服摄入方法。公司技术可应用于多种治疗适应症，包括高血压和心脏病、糖尿病等。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.120502},{"month":2,"riseRate":0.333333,"avgChangeRate":0.193473},{"month":3,"riseRate":0.5,"avgChangeRate":0.016119},{"month":4,"riseRate":0,"avgChangeRate":-0.18546},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.108981},{"month":6,"riseRate":0.333333,"avgChangeRate":0.014329},{"month":7,"riseRate":0.5,"avgChangeRate":0.023545},{"month":8,"riseRate":0.5,"avgChangeRate":0.201949},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.178656},{"month":10,"riseRate":0.4,"avgChangeRate":0.009311},{"month":11,"riseRate":0.6,"avgChangeRate":0.063722},{"month":12,"riseRate":0.2,"avgChangeRate":-0.199908}],"exchange":"NASDAQ","name":"Lexaria Bioscience Corp","nameEN":"Lexaria Bioscience Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lexaria Bioscience Corp(LEXX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lexaria Bioscience Corp(LEXX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lexaria Bioscience Corp,LEXX,Lexaria Bioscience Corp股票,Lexaria Bioscience Corp股票老虎,Lexaria Bioscience Corp股票老虎国际,Lexaria Bioscience Corp行情,Lexaria Bioscience Corp股票行情,Lexaria Bioscience Corp股价,Lexaria Bioscience Corp股市,Lexaria Bioscience Corp股票价格,Lexaria Bioscience Corp股票交易,Lexaria Bioscience Corp股票购买,Lexaria Bioscience Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lexaria Bioscience Corp(LEXX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lexaria Bioscience Corp(LEXX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}